• / Free eNewsletters & Magazine
  • / My Account
Home>AstraZeneca PLC Acquisition of Rights to Actavis' Portfolio

AstraZeneca PLC Acquisition of Rights to Actavis' Portfolio

3party Content

Tue, 3 Mar 2015

TIDMAZN RNS Number : 3507G AstraZeneca PLC 03 March 2015 AstraZeneca COMPLETES acquiSITION OF rights to actavis' Branded respiratory portfolio in THE US AND CANADA Acquisition strengthens AstraZeneca's aclidinium respiratory franchise and adds immediate revenues with long-term growth potential
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.